Clinton Otwori: Which Blood Product Do Healthcare Workers Most Commonly Misunderstand in Practice?
Clinton Otwori, Perioperative Nurse at LifeCare Hospitals, shared a post on LinkedIn:
“Different blood products.
Different purposes.
Different risks.
Not every blood bag hanging in the ward or ICU serves the same purpose.
And understanding the difference can save lives.
Whole Blood still used in many emergency settings for:
- Massive blood loss
- Trauma
- Hemorrhagic shock
Provides:
- Red cells
- Plasma
- Clotting factors
- Platelets
Packed Red Blood Cells (PRBCs)
Used mainly to improve oxygen-carrying capacity in:
- Severe anemia
- Surgical blood loss
- Hemorrhage
Fresh Frozen Plasma (FFP)
Used for:
- Clotting factor replacement
- Coagulopathy
- Liver disease-related bleeding
- Massive transfusion protocols
Platelets
Used when platelet counts are dangerously low or bleeding risk is high.
Common indications include:
- Thrombocytopenia
- Active bleeding
- Platelet dysfunction
Cryoprecipitate
Rich in fibrinogen and clotting factors.
Used in:
- Low fibrinogen states
- Massive bleeding
- Selected DIC cases
The dangerous part?
Two blood products may look similar
But giving the wrong one can:
- Delay treatment
- Worsen complications
- Increase patient risk
And transfusion itself is never risk-free.
Healthcare workers should always watch for:
- Fever/chills
- Shortness of breath
- Rash/itching
- Back or flank pain
- Hypotension or tachycardia
Before any transfusion:
- Verify the patient carefully
- Confirm compatibility
- Monitor closely
- Reassess continuously
Because in critical care…
The right blood product at the right time can save a life.
Which blood product do you think healthcare workers most commonly misunderstand in practice?”
Stay updated with Hemostasis Today.
-
Jul 13, 2026, 23:39Yaariv Khaykin: Whole-Person Care Can Strengthen Stroke Prevention in Patients With Atrial Fibrillation
-
Jul 13, 2026, 22:33ESOC 2026 recordings are now available on eSTEP – European Stroke Organisation
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026